Ye Xu
About
In The Last Decade
Ye Xu
18 papers receiving 587 citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Molecular Biology 367
- Cancer Research 227
- Oncology 129
- Epidemiology 101
- Pulmonary and Respiratory Medicine 62
Countries citing papers authored by Ye Xu
This map shows the geographic impact of Ye Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Xu more than expected).
Fields of papers citing papers by Ye Xu
This network shows the impact of papers produced by Ye Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Xu. The network helps show where Ye Xu may publish in the future.
Co-authorship network of co-authors of Ye Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Ye Xu. A scholar is included among the top collaborators of Ye Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Xu. Ye Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | 2 | |
| 4 | 5 | |
| 5 | 41 | |
| 6 | 11 | |
| 7 | CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma breakdown → | 155 |
| 8 | 25 | |
| 9 | 12 | |
| 10 | 6 | |
| 11 | 31 | |
| 12 | 41 | |
| 13 | 22 | |
| 14 | 74 | |
| 15 | 59 | |
| 16 | 45 | |
| 17 | 50 | |
| 18 | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.